https://de.marketscreener.com/kurs/aktie/BASILEA-PHARMACEUTICA-AG-130199/news/Basilea-erwirbt-praklinisches-Antibiotika-Programm-von-Spexis-45738199/?utm_source=telegram&utm_medium=social&utm_campaign=share